- Home
- SOUNW vs ITRM Comparison
SOUNW vs ITRM Comparison
Compare SOUNW & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOUNW
- ITRM
- Stock Information
- Founded
- SOUNW 2005
- ITRM 2015
- Country
- SOUNW United States
- ITRM Ireland
- Employees
- SOUNW 842
- ITRM N/A
- Industry
- SOUNW EDP Services
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- SOUNW Technology
- ITRM Health Care
- Exchange
- SOUNW Nasdaq
- ITRM Nasdaq
- Market Cap
- SOUNW N/A
- ITRM 37.7M
- IPO Year
- SOUNW N/A
- ITRM 2018
- Fundamental
- Price
- SOUNW $2.95
- ITRM $1.05
- Analyst Decision
- SOUNW
- ITRM Strong Buy
- Analyst Count
- SOUNW 0
- ITRM 1
- Target Price
- SOUNW N/A
- ITRM $5.00
- AVG Volume (30 Days)
- SOUNW 104.1K
- ITRM 300.3K
- Earning Date
- SOUNW 02-27-2025
- ITRM 05-12-2025
- Dividend Yield
- SOUNW N/A
- ITRM N/A
- EPS Growth
- SOUNW N/A
- ITRM N/A
- EPS
- SOUNW N/A
- ITRM N/A
- Revenue
- SOUNW $67,297,000.00
- ITRM N/A
- Revenue This Year
- SOUNW N/A
- ITRM N/A
- Revenue Next Year
- SOUNW N/A
- ITRM $150.10
- P/E Ratio
- SOUNW N/A
- ITRM N/A
- Revenue Growth
- SOUNW 76.05
- ITRM N/A
- 52 Week Low
- SOUNW $4.84
- ITRM $0.81
- 52 Week High
- SOUNW $6.16
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- SOUNW N/A
- ITRM 30.57
- Support Level
- SOUNW N/A
- ITRM $1.05
- Resistance Level
- SOUNW N/A
- ITRM $1.16
- Average True Range (ATR)
- SOUNW 0.00
- ITRM 0.08
- MACD
- SOUNW 0.00
- ITRM -0.00
- Stochastic Oscillator
- SOUNW 0.00
- ITRM 0.00
About SOUNW SoundHound AI Inc. Warrant
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.